Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 143.26 |
| Open | 143.99 |
| Bid | 143.71 x 800 |
| Ask | 143.90 x 1300 |
| Day's range | 138.22 - 144.89 |
| 52-week range | 115.61 - 497.49 |
| Volume | |
| Avg. volume | 6,101,277 |
| Market cap | 57.385B |
| Beta (5Y monthly) | 1.69 |
| PE ratio (TTM) | 4.24 |
| EPS (TTM) | 34.02 |
| Earnings date | 03 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 219.33 |
- Zacks
Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates
The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).
- Yahoo Finance Video
CDC endorses Moderna's COVID vaccine for kids 6 to 17 years old
Yahoo Finance's Rachelle Akuffo looks at Moderna's stock following a CDC panel's endorsement of its latest vaccine.
- Zacks
Moderna (MRNA) Reveals New Data on Bivalent COVID Booster
Moderna's (MRNA) bivalent COVID booster candidate exhibits a greater than a 5-fold boost in antibody responses against the Omicron subvariants BA.4 and BA.5 in a phase II/III study.
© 2022 Yahoo. All rights reserved.
